BRCA: New Chemotherapy Regime Proves to Shrink Tumours Twice as Fast

A new chemotherapy regime has proved to shrink tumours twice as fast as in normal methods in patients with aggressive breast cancer carrying a faulty BRCA gene, according to a clinical trial.